A nurse is assisting with the care of a client in an outpatient primary care provider's office. Complete the diagram by dragging from the choices below to specify what condition the client is most likely experiencing, 2 actions the nurse should take to address that condition, and 2 parameters the nurse should monitor to assess the client's progress.
Explanation & Rationale
A client with a history of hypertension, chronic kidney disease, and alcohol intake presenting with sudden severe pain in the right great toe suggestive of gout. Gout is an inflammatory arthritis caused by deposition of monosodium urate crystals in joints due to hyperuricemia. Classic presentation includes sudden onset of intense pain, redness, warmth, and swelling of the first metatarsophalangeal joint (podagra). Management includes reducing uric acid levels, controlling inflammation, and monitoring symptom progression. Rationale for correct choices: • The client’s presentation is highly consistent with acute gout, which is caused by deposition of monosodium urate crystals in the joint due to hyperuricemia. The sudden onset of severe pain in the right great toe (podagra), along with redness, warmth, and tenderness, is a classic hallmark of a gout flare. The client also has multiple risk factors, including chronic kidney disease (reduced uric acid excretion), hypertension, and regular alcohol intake (red wine), all of which contribute to elevated uric acid levels. These combined findings strongly support gout. • Gout is caused by elevated uric acid levels, which are influenced by dietary purines found in foods such as red meat, seafood, and alcohol (especially red wine, which the client consumes regularly). A low purine diet helps reduce uric acid production and prevents further crystal deposition in joints. Dietary modification is a key long-term management strategy in gout. • Colchicine is a first-line medication used to treat acute gout flares by reducing inflammation caused by urate crystal deposition. It works by inhibiting neutrophil activity and decreasing the inflammatory response in the affected joint. The client’s presentation of sudden, severe pain in the great toe with redness and warmth is classic for acute gout. Early administration helps reduce duration and severity of the flare. • Pain level is a critical parameter for monitoring the progression and response to treatment in acute gout. Gout flares are typically extremely painful, and improvement in pain indicates reduction in inflammation and crystal-induced irritation. Tracking pain allows the nurse to evaluate effectiveness of medications such as colchicine or NSAIDs. It also helps guide mobility and comfort interventions during the acute phase. • Serum uric acid level directly reflects the underlying metabolic disturbance causing gout. Elevated uric acid supports the diagnosis and helps assess long-term risk of recurrent flares. Monitoring this level is important for evaluating response to dietary changes and urate-lowering therapy. It provides objective data on disease control beyond symptom relief. Rationale for incorrect choices: • A fracture typically presents with a clear history of trauma, such as a fall or direct injury, which this client denies. While fractures can cause localized pain and swelling, they are usually associated with deformity, bruising, or inability to bear weight rather than isolated redness and warmth of a single joint. The sudden severe pain in the great toe without injury history is not characteristic of a bone fracture. • Shingles (herpes zoster) presents with a unilateral, dermatomal rash that progresses from erythema to vesicles and crusting, often accompanied by burning or tingling pain. The client does not have any visible rash or skin lesions, which are hallmark features of shingles. Additionally, shingles pain is neuropathic and follows a nerve distribution rather than being localized to a single joint. • Septic arthritis is a joint infection that typically presents with severe joint pain, swelling, warmth, and often systemic signs such as fever and elevated WBC count. Although the client has joint redness and pain, there is no report of fever, chills, or systemic infection markers. The involvement of the great toe and risk factors like alcohol use and CKD are more consistent with gout rather than infection. Therefore, septic arthritis is less likely in this scenario. • Methotrexate is a disease-modifying antirheumatic drug (DMARD) used primarily for autoimmune conditions such as rheumatoid arthritis, not gout. Gout is not an autoimmune disorder but a metabolic condition involving uric acid accumulation. Therefore, methotrexate does not address the underlying pathophysiology of this condition. It would not be appropriate for acute gout management. • Although imaging may sometimes be used to rule out fractures or chronic joint damage, gout is primarily diagnosed clinically and supported by serum uric acid levels. The client’s presentation is classic for gout, making imaging unnecessary for initial management. X-rays do not detect uric acid crystals during acute flares. • Antibiotics are indicated for infectious causes such as septic arthritis or cellulitis, but there is no evidence of infection in this client. The affected joint is inflamed due to crystal deposition rather than bacterial invasion. The absence of fever and systemic infection signs further supports a noninfectious etiology. • Temperature is more relevant for infectious conditions such as septic arthritis or cellulitis. The client’s presentation does not suggest systemic infection, and fever is not a typical feature of uncomplicated gout. While monitoring for infection is always important, it is not a primary marker for gout progression. • Rash is associated with conditions such as shingles or allergic reactions, not gout. The client’s symptoms are localized to a single joint with redness and swelling rather than a diffuse skin eruption. There is no indication of viral or dermatologic involvement. Therefore, rash is not a relevant parameter for monitoring gout. • A complete blood count is not specific for gout and is more useful in identifying infection or systemic inflammation. While mild elevation in WBC may occur due to inflammation, it does not directly monitor gout progression. Serum uric acid and symptom severity are more relevant indicators. Therefore, CBC is not the best monitoring tool in this scenario.